HER2阳性晚期乳腺癌命运 郁金香

ESMO21 Expert Video Report on HER2-positive metastatic breast cancer: Reporting from the ESMO Congress 2021, Cristina Saura describes the outstanding results from the DESTINY-Breast03 study (LBA1) and the promising results from the TULIP trial (LBA15).